Kretz Florian Tobias Alwin, Tarib Imane, Teisch Swetlana, Kaiser Insa, Lucchesi Rafaela, Herbers Claudia, Hinkens Annalena, Hagen Philipp, Breyer Detlev R H
International Vision Correction Research Centre Network (IVCRC.net), University of Heidelberg, Heidelberg.
Augentagesklinik Rheine, Germany.
Klin Monbl Augenheilkd. 2018 Aug;235(8):874-880. doi: 10.1055/a-0600-2826. Epub 2018 Jul 13.
Modern intraocular lens surgery has made great progress over the last few years towards creating independency of spectacles in daily life. Especially in the areas of distant and near visual acuity, optimisation has been possible. Nevertheless, with new media and requirements in professional life, there is an increasing need for optimisation of the intermediate range. In a prospective, non-randomised clinical study, the functional and refractive results after implantation of a novel intraocular lens with enhanced depth of focus were analysed.
PATIENTS/MATERIAL AND METHODS: We have evaluated eleven patients after binocular implantation of the AT LARA 829MP (Carl Zeiss Meditec AG, Germany) 3 months after surgery. We examined refraction, corrected and uncorrected monocular and binocular distant visual acuity (CDVA, UDVA) as well as distance-corrected monocular and binocular visual acuity at different intermediate distances (with DCIVA 90, 80 and 60 cm) and 40 cm (DCNVA). We also performed defocus curve analysis.
We found a mean increase of monocular CDVA from 0.35 to - 0.01 logMAR. Binocular DCIVA at 90, 80 and 60 cm was - 0.07, 0.04 and 0.07 logMAR, respectively. Even with a principle focus on intermediate distances, we found a functional DCNVA of 0.33 logMAR. Defocus curve analysis showed a visual acuity of 0.3 logMAR in a range of - 2.5 D to + 1.0 D.
Binocular implantation of the AT LARA 829MP targeting emmetropia gives stable visual acuity from the distant to the near intermediate range, still with functional vision at the near distance of 40 cm.
在过去几年中,现代人工晶状体手术在实现日常生活中摆脱眼镜依赖方面取得了巨大进展。特别是在远视力和近视力领域,已经实现了优化。然而,随着新媒体的出现和职业生活中的新需求,对中距离视力优化的需求日益增加。在一项前瞻性、非随机临床研究中,分析了植入具有增强景深的新型人工晶状体后的功能和屈光结果。
患者/材料与方法:我们评估了11例患者,在双眼植入AT LARA 829MP(德国卡尔蔡司医疗技术股份公司)3个月后进行评估。我们检查了验光、矫正和未矫正的单眼及双眼远视力(矫正远视力、未矫正远视力),以及在不同中距离(90、80和60厘米)和40厘米(近中距离矫正视力)下的距离矫正单眼和双眼视力。我们还进行了散焦曲线分析。
我们发现单眼矫正远视力平均从0.35提高到-0.01 logMAR。90、80和60厘米处的双眼中距离矫正视力分别为-0.07、0.04和0.07 logMAR。即使主要关注中距离,我们发现近中距离矫正视力为0.33 logMAR。散焦曲线分析显示在-2.5 D至+1.0 D范围内视力为0.3 logMAR。
以正视化为目标的双眼植入AT LARA 829MP可提供从远到近中距离的稳定视力,在40厘米近距离仍有功能性视力。